hot penny stocks for 2010, page-32

STI, 1.3c close on Thursday, within pharma/bio arena.

-- Market cap of around $12/13m atm.
-- Projected to be bringing in revenue's of around $36m by years end 2010, cash burn for the year projected at $2.7m.
-- New deals being done for generic sales in Aust, amongst others.

Only have a few toes in currently but may get in up to the ankles at least as more unfolds. Management seem to be on the right track, not a trade for me but a longer term investment in a company who's market cap seems silly if these revenues are to be turned over, even at 30% profit and 8x earnings they look very attractive.

By no means take this as advice................